4/A
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-117940
Chief Technical Officer acquired 69,160 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Option exercise 10b5-1 | +65,175 | $21.38 | $1,393,442 | 70,415 | D |
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Option exercise 10b5-1 | +3,985 | $6.80 | $27,098 | 74,430 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Option exercise · Stock Option (right to buy) 10b5-1 | −65,175 | 10,625 | D | ||
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,985 | 31,875 | D | ||
Loading xslF345X05/tm2428383-2_4aseq1.xml…